WASHINGTON (AP) — A high-ranking Senate Democrat is scrutinizing links between pharmaceutical companies and government advisers who recently criticized efforts to reduce painkiller prescribing.
Search Results - stltoday.com, St. Louis Post-Dispatch: Business
Mon, 02/08/2016 - 8:34am
WASHINGTON (AP) — A high-ranking Senate Democrat is scrutinizing links between pharmaceutical companies and government advisers who recently criticized efforts to reduce painkiller prescribing.